Sentinel lymph node biopsy in patients with breast cancer ycT4N0M0 after neoadjuvant drug therapy
https://doi.org/10.17650/1994-4098-2024-20-1-59-63
Abstract
Sentinel lymph node biopsy is an effective clarifying diagnostic method that is actively used in various malignancies, including breast cancer. The effectiveness of this method has led to a potential expansion of the standard indications for its use. This article is devoted to the study of the effectiveness of sentinel lymph node biopsy based on world literature data regarding the use of ycT4N0M0 in patients with breast cancer after neoadjuvant drug therapy.
About the Authors
M. B. Kurbanova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Mavzuna Bakhromovna Kurbanova
24 Kashirskoe Shosse, Moscow 115522, Russia
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов
M. A. Frolova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
24 Kashirskoe Shosse, Moscow 115522, Russia
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов
F. Kh. Shidakova
Russian University of Medicine, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Build. 1, 20 Delegatskaya St., Moscow 127473, Russia
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов
V. A. Amosova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
24 Kashirskoe Shosse, Moscow 115522, Russia
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов
K. V. Gagulaeva
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
24 Kashirskoe Shosse, Moscow 115522, Russia
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов
M. A. Margusheva
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
24 Kashirskoe Shosse, Moscow 115522, Russia
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов
E. V. Yangirova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
24 Kashirskoe Shosse, Moscow 115522, Russia
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов
A. V. Petrovskiy
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
24 Kashirskoe Shosse, Moscow 115522, Russia
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов
References
1. Ermoshchenkova M.V., Zikiryakhodzhaev A.D., Filonenko E.V. Federal clinical guidelines for the diagnosis and treatment of postmastectomy syndrome. Vestnik vosstanovitelnoy meditsiny = Journal of Restorative Medicine 2014;(5):68–84. (In Russ.).
2. Galimberti V., Chifu C., Rodriguez Perez S. et al. Positive axillary sentinel lymph node: Is axillary dissection always necessary? Breast 2011;20(Suppl 3):S96–S98. DOI: 10.1016/s0021-7697(07)79774-0
3. Kilbreath S.L., Refshauge K.M., Beith J.M. et al. Risk factors for lymphoedema in women with breast cancer: A large prospective cohort. Breast 2016;28:29–36. DOI: 10.1016/j.breast.2016.04.011
4. Mansel R.E., Fallowfield L., Kissin M. et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. Randomized Controlled Trial. J Natl Cancer Inst 2006;98(9): 599–609. DOI: 10.1093/jnci/djj158
5. Langer I., Guller U., Berclaz G. et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery. Ann Surg 2007;245(3):452–61. DOI: 10.1097/01.sla.0000245472.47748.ec
6. Jo H., Lee E., Song E. et al. Comparison of clinical outcomes between sentinel lymph node biopsy and axillary lymph node dissection in a single-center Z0011-eligible breast cancer cohort. Korean J Clin Oncol 2020;16(1):18–24. DOI: 10.14216/kjco.20004
7. Lin Sh.-Q., Vo N.-Ph., Yen Y.-Ch. et al. Outcomes of sentinel node biopsy for women with breast cancer after neoadjuvant therapy: Systematic review and meta-analysis of real-world data. Ann Surg Oncol 2022;29(5):3038–49. DOI: 10.1245/s10434-021-11297-z
8. Franceschini G., Di Leone A., Martin Sanchez A. et al. Update on sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patient. Ann Ital Chir 2020;91:465–8.
9. Damin A.P., Zancan M., Melo M.P. et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with nodepositive breast cancer: Guiding a more selective axillary approach. Breast Cancer Res Treat 2021;186(2):527–34. DOI: 10.1007/s10549-020-06011-8
10. Galimberti V., Ribeiro Fontana S.K., Maisonneuve P. et al. Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment. Eur J Surg Oncol 2016;42(3):361–8. DOI: 10.1016/j.ejso.2015.11.019
11. De Oliveira-Junior I., Nahas E.A.P., Cherem A.C. et al. Sentinel lymph node biopsy in T3 and T4b breast cancer patients: Analysis in a tertiary cancer hospital and systematic literature review. Breast Care 2021;16:27–35. DOI: 10.1159/000504693
12. Elnahas W., Hamdy O., Abdel Wahab K. et al. Accuracy of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients: Single center experience. Surg Sci 2018;9(1):52–61 DOI: 10.4236/ss.2018.91006
13. Andreis D., Bonardi S., Allevi G. et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer. Breast 2016;29:55–61. DOI: 10.1016/j.breast.2016.07.003
Review
For citations:
Kurbanova M.B., Frolova M.A., Shidakova F.Kh., Amosova V.A., Gagulaeva K.V., Margusheva M.A., Yangirova E.V., Petrovskiy A.V. Sentinel lymph node biopsy in patients with breast cancer ycT4N0M0 after neoadjuvant drug therapy. Tumors of female reproductive system. 2024;20(1):59-63. (In Russ.) https://doi.org/10.17650/1994-4098-2024-20-1-59-63
Views:
314
Email this article 